top of page

Our Company.

Culturon is at the forefront of biotechnological innovation, specialising in plasma-treated surfaces that significantly improve biomolecule attachment. Our technology offers vast applications across scientific research, making us a leader in our field.

A Growing Opportunity.

Culturon presents a compelling investment opportunity with a global impact, uniquely positioned within the rapidly evolving biotechnology landscape. Since our founding in 2022, we have experienced rapid growth, demonstrating our capacity to scale and adapt in a highly competitive market. Our innovative plasma-treated surface technology, already available to the scientific community, is setting new standards in the efficiency and efficacy of biomolecule attachment.

Intellectual Property

Owning our intellectual property outright allows us to fully control the development and commercialisation of our plasma-treated surface technology. This exclusivity ensures that all commercial benefits, including potential licensing deals or product expansions, flow directly back to the company and its investors, securing a competitive edge and safeguarding our market position.

​

Culturon is currently securing its innovative position with a pending patent in Australia and has initiated the process for global filing to protect and expand our technology worldwide. We also have a registered trademark in Australia and New Zealand.

Get in Touch.

We invite forward-thinking investors to join us on this remarkable journey. If you are looking to invest in a company at the forefront of scientific advancement with substantial market potential, we encourage you to get in touch.

 

Discover how your investment can contribute to shaping the future of biotechnology and generate significant returns.

Thanks for your interest.

  • LinkedIn

Culturon would like to acknowledge the Indigenous people who are the Traditional Custodians of this land we work and live on. We pay our respects to the Elders past, present, and emerging.

Culturon © 2026 

bottom of page